Willpharma

Willpharma partnered with ESGlogic to structure an ESG scan, a three-pillar action plan and a detailed carbon footprint, culminating in a VS (ex VSME) Bronze medal.

PharmaStarted in October 2024Completed

Services provided

VS (ex VSME) ReportingCarbon Footprint

Who they are

Willpharma is a family-owned, independent pharmaceutical company founded in 1924 in Amsterdam. Based in Bierges, Belgium, it develops and markets medicines, medical devices and food supplements, with a strong presence in the Benelux and export partners abroad. Its compact size, between 11 and 50 employees, supports fast decision-making and a quality-first approach for patients.

How we structured their ESG approach

The engagement began with an ESG scan, establishing a baseline of existing practices across environmental, governance and social dimensions, covering both employees and clients and partners. This diagnostic formed the basis for a structured action plan built around three pillars, assess, structure and transform, spanning materiality and KPIs as well as governance, training, procurement and mobility. In parallel, Willpharma carried out its 2024 carbon footprint, with a detailed breakdown by emission source. A roadmap was defined to refine scope 3 granularity for the 2025 footprint, with more precise categorisation of pharmaceutical purchases and the integration of supplier emissions data. This approach enabled Willpharma to earn the VS (ex VSME) Bronze medal.

Key insights

Bronze

8.4k tCO2e

41.6%

Key takeaways

Want to achieve the same results as Willpharma?

Like Willpharma, structure your ESG approach and accelerate your path toward measurable, lasting impact. Let's talk about your goals in a no-commitment call.

Book a meeting

And where does your company stand on ESG?

A few questions are all it takes to get your ESG score, your priority areas and the EU regulations that apply to you.

Assess my ESG score